Avella Selected by Array BioPharma Inc. to distribute BRAFTOVI(TM) (encorafenib) and MEKTOVI(R) (binimetinib)
The specialty pharmacy will give patients access to this important new FDA-approved combination therapy for patients with advanced BRAF melanoma
PHOENIX, June 28, 2018 -- (Healthcare Sales & Marketing Network) -- Avella has announced that it will distr... Biopharmaceuticals, Oncology, Distribution Avella, Array BioPharma, BRAFTOVITM, encorafenib, MEKTOVI, binimetinib
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news